Skip to main content
. Author manuscript; available in PMC: 2022 Jul 1.
Published in final edited form as: Clin Exp Rheumatol. 2021 Mar 10;39(Suppl 131):43–51. doi: 10.55563/clinexprheumatol/9ivp9g

Table 2:

Causes for hospitalizations related to systemic sclerosis, for the overall group and stratified by presence or absence of interstitial lung disease

Total Admissions for all patients With ILD Without ILD
Reasons for Hospitalization Total Admissions* Elective Admissions LOS, days (mean) Total Admissions* Total Admissions*
All Scleroderma related 382 125 5.5 (6.4) 231 151
Digital Vasculopathy 100 77 4.3 (2.4) 39 61
Intravenous Prostacyclin (epoprostenol) 100 77 4.3 (2.4) 39 61
Gastroenterology 91 0 5.2 (6.3) 49 42
GI dysmotility-upper 21 0 3.9 (2.7) 5 16
GI bleed 23 0 3.2 (2.9) 15 8
Gastritis/Ulcer 23 0 3.8 (2.7) 18 5
GI Dysmotility – Lower 21 0 10.5(10.8) 9 12
Small Intestinal Bowel Overgrowth 3 0 4.7(3.1) 2 1
Cardiovascular 54 5 4.1(3.5) 40 14
Pericarditis/ Pericardial Effusion 8 0 5.4(3.9) 6 2
Arrythmias 30 5 3.4(3.3) 20 10
Systolic Heart Failure 9 0 5.0(4.6) 9 0
Diastolic Heart Failure 7 0 4.3 (2.0) 5 2
Cardiopulmonary 46 2 7.0 (7.4) 28 18
Pulmonary Hypertension 46 2 7.0 (7.4) 28 18
Treatment/Infusion-related 37 36 5.4 (7.6) 34 3
Rituximab/Cyclophosphamide Infusions 31 30 2.2 (1.5) 28 3
Stem Cell Transplant 6 6 21.8 (3.9) 6 0
Renal 25 5 9.9 (11.9) 19 6
Scleroderma Renal Crisis 11 0 15.6 (15.7) 9 2
HTN Urgency 4 0 6.8 (7.7) 3 1
HTN Emergency 5 0 6.8 (4.1) 3 2
Renal Transplant/ Rejection 5 5 3.0 (1.2) 4 1
Pulmonary Involvement 19 0 7.4 (9.7) 18 1
Aspiration Pneumonitis 7 0 9.0 (12.9) 6 1
Interstitial Lung Disease 12 0 6.5 (7.8) 12 0
Malnutrition/Failure to Thrive 7 0 5.0 (2.4) 4 3
Musculoskeletal 3 0 5.3 (3.2) 0 3
Myositis/Myonecrosis 3 0 5.3 (3.2) 0 3

Abbreviations: GI=gastrointestinal; HTN=Hypertension; LOS=length of Stay;

*

Total Admissions refers to all elective and emergent or urgent admissions.